This NDC is on FDA's drug shortage list (posted Mar 23, 2018)
Product Information
KETOROLAC 60 MG/2 ML VIAL is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.5524 per ML under NDC 62332060125. Its NADAC has been published 173 times since Jun 14, 2023.
FDA first approved this application on Nov 2, 2022. Its Orange Book therapeutic-equivalence code is AP.
Strength
60 mg/2mL
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332060125
Classification
Generic
Dosage Form
INJECTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
9/23/2026
Active Ingredients
KETOROLAC TROMETHAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA214456FDA Approved
11/2/2022
TE Code
AP
On Market Since
11/2/2022
Pharmacological Classes
Price Statistics
The NADAC for KETOROLAC 60 MG/2 ML VIAL has been published 173 times since Jun 14, 2023, and over the history we have for it it has declined 19.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5524 per ML |
|---|---|
| All-time high | $0.8748 (Jun 12, 2024) |
| All-time low | $0.4543 (Feb 18, 2026) |
| 52-week high | $0.5738 |
| 52-week low | $0.4543 |
| Median price | $0.6435 |
| Average price | $0.6459 |
| Largest weekly change | +18.1% (Jul 19, 2023) |
| Weeks tracked | 173 |
| Tracking since | Jun 14, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Ketorolac Tromethamine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alembic Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ketorolac Tromethamine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cyclooxygenase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of KETOROLAC 60 MG/2 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for KETOROLAC 60 MG/2 ML VIAL, manufactured by Alembic Pharmaceuticals Inc., is $0.5524 per ML (NDC 62332060125), effective Sep 30, 2026.
How has the price of KETOROLAC 60 MG/2 ML VIAL changed over time?
Over the history we have for it, the NADAC for KETOROLAC 60 MG/2 ML VIAL has declined 19.4%. It has been tracked across 173 weekly CMS publications since Jun 14, 2023.
What are the highest and lowest recorded NADAC prices for KETOROLAC 60 MG/2 ML VIAL?
Since Jun 14, 2023, the NADAC for KETOROLAC 60 MG/2 ML VIAL has ranged from a low of $0.4543 (Feb 18, 2026) to a high of $0.8748 (Jun 12, 2024), with a median of $0.6435 per ML.
Are there cheaper alternatives to KETOROLAC 60 MG/2 ML VIAL?
No other NADAC-published product currently shares the active ingredient and strength of KETOROLAC 60 MG/2 ML VIAL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures KETOROLAC 60 MG/2 ML VIAL?
KETOROLAC 60 MG/2 ML VIAL (NDC 62332060125) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.
Is KETOROLAC 60 MG/2 ML VIAL in shortage?
Yes — NDC 62332060125 is currently listed in FDA's drug shortage database (posted Mar 23, 2018).